LipoQuick + GLP-1/GIP Contains Tirzepatide, Vitamin B12, Methionine, Inositol Compounded oral blend of Tirzepatide, Vitamin B12, Methionine, Inositol formulated to support fat metabolism, liver function, and balanced metabolic energy for those preferring a non-injectable option
The 8mg dose achieved 22.8% body weight reduction at 48 weeks, while 12mg achieved 24.2%, a difference of 1.4 percentage points
Given that the glucose-lowering effect of metformin is so strong and is independent of incretin signalling, it might be difficult to detect the beneficial effect of metformin on the incretin axis in human studies
Case Story Jasmine's Reset Jasmine , age 55, BMI 34, was newly diagnosed with type 2 diabetes (A1C 7.9%)
(2023) Retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in type 2 diabetes The New England Journal of Medicine 389(6):503-513
The cardiovascular safety profile of tirzepatide has been evaluated through large-scale clinical trials, most notably the SURPASS programme and the SURMOUNT studies